Physician profile

Michael S Mayer

Optometrist · Hanford, CA

NPI 1023161775

$1,780.28

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$998.65

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bausch & Lomb Americas INC. $885.30 2022-2024 Infuse, Biotrue, Alden Scleral Zenlens
Coopervision INC. $500.00 2021
Lkc Technologies, INC. $141.45 2023
Johnson & Johnson Vision Care, INC. $108.17 2024
Optos, INC. $81.94 2019
Carl Zeiss Meditec Ag $38.80 2020
Bausch & Lomb, A Division of Bausch Health US, LLC $24.62 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael S Mayer

$1,780.28

in general payments reported 2019-2025

Years
2019-2024
Top company
Bausch & Lomb Americas INC.

https://glasscript.com/doctor/363960/michael-s-mayer

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.